Atlas Trials

Efficacy and Safety of Lixisenatide Versus Insulin Glulisine on Top of Insulin Glargine With or Without Metformin in Type 2 Diabetic Patients

Clinical trial NCT01768559 · COMPLETED

Trial details

NCT number
NCT01768559
Sponsor
Sanofi
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Type 2 Diabetes
Start date
2013-01-01
Primary completion
2014-12-01
Enrollment
894

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.